Press Releases

  • GOED Celebrating 10th Anniversary; Appoints New Officers

    GOED, the Global Organization for EPA and DHA Omega-3s, is celebrating its 10th anniversary supporting the EPA and DHA omega-3 industry. The organization was founded in 2006 as a spin-off of an omega-3 working group within the Council for Responsible Nutrition (CRN) and has made significant strides in its objectives to promote the consumption of EPA and DHA and protect the category by assuring it makes quality products that consumers can trust. 

  • GOED Signs Partnership with US-CHPA for Increased China Presence

    GOED, the Global Organization of EPA and DHA Omega-3s (GOED), has signed a memorandum of understanding with the US-China Health Products Association (US-CHPA) to form a partnership that helps GOED better serve its member companies. 

  • GOED Publishes Report on Omega-3 Finished Products

    GOED, the Global Organization of EPA and DHA Omega-3s, has published a report detailing the 2015 market for finished products containing EPA and DHA omega-3s. According to GOED’s proprietary research, the worldwide finished products market for 2015 was $31.4 billion. 

  • GOED Publishes EPA and DHA Intake Recommendations

    GOED, the Global Organization of EPA and DHA Omega-3s, recently published an infographic detailing its recommendations for daily intake of EPA and DHA omega-3 fatty acids.

  • New Study Supports Link Between Omega-3 Supplementation and Reduction in Depression

    A new meta-analysis published inTranslational Psychiatry supports the link between intake of EPA and DHA omega-3 fatty acids, the kind found in fish, and reduction in major depressive disorder (MDD).

  • GOED Presents Two Achievement Awards

    GOED recently presented two achievement awards at its GOED Exchange 2016 conference. The awards were given to Bjorn Rene, currently Sales Director at Golden Omega, and jointly to Clemens von Schacky, Head of Preventive Cardiology at the University of Munich and Bill Harris, Professor of Medicine, University of South Dakota School of Medicine and President and CEO, OmegaQuant Analytics.

  • New Study Highlights Potential US Public Health Impact of Fish Oil

    A new study published in Lipid Technology highlights the potential positive impact of consumption of oil derived from menhaden, a U.S.-caught fish high in the omega-3s EPA and DHA, on public health across the country.

  • Paper Highlights Best Practices for Omega-3 Trials with Cardiovascular Outcomes

    A paper published this week in the journal Prostaglandins, Leukotrienes and Essential Fatty Acids sheds new light on recent neutral studies questioning the benefits of omega-3s for heart health.

  • New Research Shows Omega-3 Consumption Reduces the Risk of Pre-Term Birth by 58%

    A study found that omega-3 supplement consumption was associated with a 58 percent decrease in the likelihood of early preterm birth (babies born before 34 weeks) and a 17 percent decrease in any preterm delivery (babies born before 37 weeks). In addition, the data shows a longer gestation period and higher average infant birth weight.

  • GOED Issues New Update to its Voluntary Monograph

    Continuing its important focus on omega-3 quality, GOED, the Global Organization of EPA and DHA Omega-3s, has published an update to its GOED Voluntary Monograph, which is among the strictest quality standards in the international omega-3 industry.